Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$9.44 - $13.3 $825,669 - $1.16 Million
-87,465 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$9.3 - $25.16 $813,424 - $2.2 Million
87,465 New
87,465 $827,000

Others Institutions Holding CNTG

About Centogene N.V.


  • Ticker CNTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,081,600
  • Market Cap $10.3M
  • Description
  • Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...
More about CNTG
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.